TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | 4 | 4 | 3 | 60 | 36 | 55 | 27 |
P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/7/21 21:53 | 6/3/21 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Stack David M | NJ | D | P.m | 68 | 4.56 | 0 | 15 | 60 | 40 | I | |||||||||||||||
12/2/20 20:05 | 11/30/20 | AMRN | Amarin Corp Plcuk | X0 | Health | Drug | Pharmaceutical Preparations | Stack David M | NJ | D | P | 122 | 4.86 | 0 | 25 | New | 25 | I | |||||||||||||||
12/1/20 19:40 | 11/30/20 | CHMA | Chiasma, Inc | DE | Health | Drug | Pharmaceutical Preparations | Stack David M | MA | D | P | 107 | 4.27 | 0 | 25 | New | 25 | I | |||||||||||||||
2/11/11 15:29 | 2/10/11 | PCRX | Pacira Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Stack David M | CA | DO | P,CEO | P | 33 | 6.60 | 3 | 5 | 27 | 24 | D | -6 | 4 | 4 | 3 | 60 | 36 | 55 | |||||||
3/17/09 14:01 | 3/16/09 | BITI | Bio Imaging Technologies Inc | DE | Health | Biolab | Testing Laboratories | Stack David M | PA | D | P | 5 | 3.43 | 0 | 2 | 9 | 19 | ||||||||||||||||
3/11/09 10:24 | 3/9/09 | BITI | Bio Imaging Technologies Inc | DE | Health | Biolab | Testing Laboratories | Stack David M | PA | D | P | 5 | 3.00 | 0 | 2 | 9 | 18 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |